ASB Consultores’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36M | Hold |
16,442
| – | – | 0.91% | 19 |
|
|
2025
Q1 | $1.33M | Hold |
16,442
| – | – | 0.87% | 17 |
|
|
2024
Q4 | $1.48M | Hold |
16,442
| – | – | 0.62% | 27 |
|
|
2024
Q3 | $1.62M | Hold |
16,442
| – | – | 0.64% | 24 |
|
|
2024
Q2 | $1.52M | Sell |
16,442
-8,767
| -35% | -$813K | 0.55% | 22 |
|
|
2024
Q1 | $2.39M | Buy |
25,209
+8,767
| +53% | +$832K | 0.62% | 22 |
|
|
2023
Q4 | $1.47M | Hold |
16,442
| – | – | 0.49% | 25 |
|
|
2023
Q3 | $1.2M | Buy |
16,442
+7,675
| +88% | +$560K | 0.47% | 27 |
|
|
2023
Q2 | $729K | Sell |
8,767
-7,675
| -47% | -$639K | 0.35% | 53 |
|
|
2023
Q1 | $1.25M | Buy |
16,442
+9,422
| +134% | +$718K | 0.5% | 29 |
|
|
2022
Q4 | $583K | Hold |
7,020
| – | – | 0.24% | 52 |
|
|
2022
Q3 | $557K | Hold |
7,020
| – | – | 0.26% | 47 |
|
|
2022
Q2 | $521K | Sell |
7,020
-329
| -4% | -$24.4K | 0.23% | 49 |
|
|
2022
Q1 | $661K | Hold |
7,349
| – | – | 0.28% | 60 |
|
|
2021
Q4 | $823K | Buy |
+7,349
| New | +$823K | 0.41% | 42 |
|